Sep 27, 2021 8:30 am EDT Acasti Pharma Announces Initiation of Pharmacokinetic Bridging Study for GTX-104, the Company’s Lead Drug Candidate for the Treatment of Subarachnoid Hemorrhage
Sep 22, 2021 8:30 am EDT Acasti Pharma Provides Update Following Acquisition of Grace Therapeutics and Regains Compliance with Nasdaq Listing Standards
Sep 14, 2021 8:30 am EDT Acasti Pharma to Present at the Oppenheimer Fall Healthcare Summit on September 21ˢᵗ
Sep 8, 2021 8:30 am EDT Acasti Pharma to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
Aug 27, 2021 8:40 am EDT Acasti Pharma Announces Successful Completion of its Merger with Grace Therapeutics, Inc., Voting Results of its Annual and Special Meeting of Shareholders and Reverse Stock Split
Jul 29, 2021 8:30 am EDT Reminder: Acasti Pharma to Host Conference Call on August 4th at 1:00 PM ET to Discuss Planned Acquisition of Grace Therapeutics
Jul 23, 2021 8:30 am EDT Acasti Pharma Schedules Conference Call for August 4th at 1:00 PM ET to Discuss Planned Acquisition of Grace Therapeutics
May 17, 2021 7:00 am EDT Acasti Intends to Request Hearing Before Nasdaq Panel to Present Plan of Compliance